Gluskin Sheff & Assoc Inc Abb Vie Inc. Transaction History

Gluskin Sheff & Assoc Inc

$772 Million
Q3 2025

A detailed history of Gluskin Sheff & Assoc Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 10,076 shares of ABBV stock, worth $2.36 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

10,076

Previous 10,496 4.0%

Holding current value

$2.36 Million

Previous $1.95 Million 19.71%

% of portfolio

0.3%

Previous 0.25%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$184.85 - $231.54 $77,637 - $97,246	-420 Reduced 4.0%	10,076 $2.33 Million
Q2 2025 Aug 14, 2025	SELL	$170.16 - $206.27 $592,837 - $718,644	-3,484 Reduced 24.92%	10,496 $1.95 Million
Q1 2025 May 15, 2025	SELL	$169.2 - $216.66 $205,070 - $262,591	-1,212 Reduced 7.98%	13,980 $2.93 Million
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $14,849 - $18,348	-90 Reduced 0.59%	15,192 $2.7 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $773 - $903	-5 Reduced 0.03%	15,282 $2.62 Million

Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $199,135 - $226,896	-1,246 Reduced 7.54%	15,287 $2.78 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $682,633 - $768,806	-4,961 Reduced 23.08%	16,533 $2.56 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $409,586 - $474,156	-3,066 Reduced 12.48%	21,494 $3.2 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $279,463 - $347,774	-2,109 Reduced 7.91%	24,560 $3.31 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $3.86 Million - $4.44 Million	26,669 New	26,669 $4.25 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $12.5 Million - $15 Million	-198,243 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $31,207 - $39,890	-475 Reduced 0.24%	198,243 $14.4 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $5.01 Million - $5.9 Million	64,990 Added 48.6%	198,718 $16 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $10.4 Million - $12.8 Million	133,728 New	133,728 $12.3 Million

Others Institutions Holding ABBV

# of Institutions

4,499

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Account

Gluskin Sheff & Assoc Inc Abb Vie Inc. Transaction History